您要查找的是不是：
- tissue factor activity 組織因子活性
- Effect of continuous blood purification on endothelial cell tissue factor activity and analysis of the correlative factors 連續性血液凈化對內皮細胞組織因子活性的影響及相關(guān)因素分析
- Rat Tissue factor pathway inhibitor,TFPI ... 大鼠組織因子途徑抑制物(TFPI)ELISA Kit；
- Rabbit Tissue factor pathway inhibitor，TFPI... 兔組織因子途徑抑制物（TFPI）試劑盒；
- Human Tissue factor pathway inhibitor，TFPI ... 人組織因子途徑抑制物（TFPI）試劑盒；
- Objective To study the clinical value of the quantities and the activity of tissue factor pathway inhibitor (TFPI) in ovarian cancer. 摘要目的：研究血漿組織因子途徑抑制物(TFPI)抗原含量及活性對卵巢癌患者的臨床意義。
- Objective To study the clinical value of the quantities and the activity of tissue factor pathway inhibitor(TFPI)on carcinoma of endometrium. 目的研究血漿組織因子途徑抑制物(TFPI)抗原含量及活性對子宮內膜癌患者的臨床意義。
- Abstract Objective To explore effects of continuous blood purification (CBP) on endothelial cell tissue factor(CTF) activity and correlation factors. 摘要 目的 探討連續性血液凈化(CBP)對體外培養內皮細胞組織因子(TF)活性的影響及其相關(guān)因素。
- Components / Effects :Aontains pliancy factor activity and wine, nutmeg, ellipsoid natural plant oil extraction cream Clean hair dirt and chemical residues. 成份/功效：蘊含活性柔順因子及月桂、豆蔻、椰油等天然植物萃取精華，清潔頭發(fā)污垢及化學(xué)殘留物。
- TFPI inhibits the effect of tissue factor, which is released during inflammation and acts as a mediator of inflammation. 組織因子旁路抑制因子（TFPI）抑制了組織因子的作用，組織因子是在炎癥過(guò)程中釋放的一種炎癥介質(zhì)。
- AIM: To evaluate the effect of tissue factor on intravascular migration of tumor cells. 目的:評價(jià)組織因子在腫瘤細胞向血管內游走過(guò)程中的作用。
- Aim:The present study was to observe the effect of thromb in on the tissue factor (TF) expression of astrocytes. 目的:觀(guān)察凝血酶對大鼠星形膠質(zhì)細胞組織因子活性表達的影響及其機制。
- The tissue factor and fl factor ate the important factor which participate the hematischesis process. 組織因子和雙因子是參與止血的重要因子，肝硬化時(shí)，兩者發(fā)生障礙。
- Tissue Factor and Platelet Glycoprotein IB-alpha Alleles Are Associated with Age at First Coronary Bypass Operation Donahue BS, et al. 組織因子和血小板糖蛋白IB-alpha等位基因與進(jìn)行第一次冠脈搭橋手術(shù)時(shí)的年齡有關(guān)。
- Objective To observe the changes of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in patients with coronary heart disease. 摘要目的觀(guān)察冠心病患者血漿組織因子(TF)、組織因子途徑抑制物(TFPI)水平的變化及其臨床意義。
- METHODS: Expression of tissue factor in tumor cells (HT1080) was analyzed by flow cytometry and immunofluorescence staining. 方法:應用流式細胞儀和免疫熒光染色法檢測組織因子在纖維肉瘤細胞(HT1080)的表達情況;
- Hoppensteadt et al. investigated the ability of topically applied MPS to release tissue factor pathway inhibitor (TFPI). Hoppensteadt等人研究了外用多磺酸粘多糖后對組織因子旁路抑制因子（TFPI）釋放的影響。
- Objective: To assess the effect of free tissue factor pathway inhibitor (f-TFPI) on the pathogenesis of acute coronary syndrome (ACS). 摘要目的：探討游離組織因子途徑抑制物(f-TFPI)在不同類(lèi)型急性冠狀動(dòng)脈綜合征(ACS)發(fā)病中的作用。
- In recent studies an activation of the tissue factor pathway inhibitor (TFPI) could be shown after cutaneous application of MPS. 最近的研究顯示，皮膚涂抹喜療妥后還能激活組織因子旁路抑制因子（TFPI）。
- plasma recognition factor activity 血漿識別因子活性
